World Scientific
Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.

Neoadjuvant/Adjuvant/Chemoprevention Therapy and Tumor Downstaging

    https://doi.org/10.1142/9789812770059_0032Cited by:2 (Source: Crossref)
    Abstract:

    The following sections are included:

    • Introduction

    • Neoadjuvant/Adjuvant/Chemoprevention Therapy in Liver Resection for HCC

      • Neoadjuvant transarterial chemoembolization (TACE)

      • Adjuvant regional chemotherapy with or without embolization

        • Adjuvant regional therapy

        • Adjuvant regional and systemic therapy

        • Neoadjuvant plus adjuvant regional therapy

      • Adjuvant systemic chemotherapy

      • Adjuvant transarterial radioembolization (TARE)

      • Adjuvant immunotherapy

      • Chemoprevention with vitamin analog therapy after curative liver resection

    • Neoadjuvant/Adjuvant Therapy in Liver Transplantation for HCC

      • Neoadjuvant TACE

      • Neoadjuvant local ablative therapy

      • Neoadjuvant multimodality therapy

      • Neoadjuvant/Adjuvant systemic chemotherapy

    • Salvage Surgery After Tumor Downstaging of Advanced HCC

      • Indication and prerequisites for salvage surgery and tumor downstaging

      • Rationale for salvage surgery after successful tumor downstaging

      • Results of salvage surgery after tumor downstaging

        • Tumor downstaging with TACE

        • Tumor downstaging with TAC

        • Tumor downstaging with multimodality therapy

      • Challenges of tumor downstaging

      • Prognosis and survival

    • References